John Conley, Mark Lotz, Stelios Papadopoulos, Sir Edwin Southern, Mike Catelani, Chris Johnson, and Robert Wicke | GenomeWeb

Alnylam CFO John Conley has resigned his position from the company, according to a recent Alnylam filing with the US Securities and Exchange Commission.

According to Alnylam, Conley’s departure became effective Jan. 31. Additional details were unavailable.

Mark Lotz has become vice president for regulatory affairs of MediciNova, the company said last week. Prior to joining the company, he worked as executive director of regulatory affairs at Isis Pharmaceuticals.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.